Abstract
While clinical environments are highly focused on COVID-19, reports of missed or delayed treatment for conditions that imitate COVID-19, such as pneumonia caused by the fungus Pneumocystis jirovecii, are emerging. Given the uncertain spectrum of COVID-19 presentations and variable sensitivity of laboratory tests for SARS-CoV-2, there is a risk that, without a high index of suspicion, alternative aetiologies may be overlooked while pursuing a diagnosis of COVID-19. The British HIV Association has been calling for the inclusion of HIV testing in all patients admitted to hospital with suspected COVID-19. In this article we reflect on the importance of including HIV testing to prevent avoidable morbidity and mortality in our patients.
| Original language | English |
|---|---|
| Pages (from-to) | 590-592 |
| Number of pages | 3 |
| Journal | Clinical Medicine |
| Volume | 20 |
| Issue number | 6 |
| DOIs | |
| Publication status | Published - 16 Nov 2020 |
Keywords
- COVID-19
- HIV
- PCP
- Pneumocystis jirovecii
- SARS-CoV-2
Access to Document
- Kelly_2020_CM_Pneumocystis-pneumonia
Copyright © 2020 Royal College of Physicians. All rights reserved. This work has been made available online in accordance with publisher policies or with permission. Permission for further reuse of this content should be sought from the publisher or the rights holder. This is the final published version of the work, which was originally published at https://doi.org/10.7861/clinmed.2020-0565.